Exscientia was an Oxford UK-based AI-driven precision medicine and drug design company, founded in 2012 as a spin-out from the University of Dundee. Its platform combined generative chemistry (Centaur Chemist) with patient tissue-based screening (EVE, an automated single-cell platform for testing drug candidates directly against patient-derived…
open-source machine-learning computational-chemistry drug-discovery drug-design precision-medicine oncology biotech pharmaceuticals apis-json acquired small-molecules generative-chemistry ai-drug-design centaur-chemist eve-platform patient-derived-screening
-
Updated
Aug 25, 2026